Homepage
Author:
CVRx, Inc.
Posted Date:
June 9, 2026
CVRx Announces Chief Financial Officer Transition
CVRx, Inc.
June 9, 2026
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
CVRx, Inc.
May 27, 2026
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
CVRx, Inc.
May 22, 2026
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
CVRx, Inc.
May 21, 2026
CVRx Reports First Quarter 2026 Financial and Operating Results
CVRx, Inc.
May 20, 2026
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
CVRx, Inc.
May 4, 2026
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
CVRx, Inc.
April 27, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
CVRx, Inc.
April 20, 2026
CVRx Reports Preliminary First Quarter 2026 Financial Results
CVRx, Inc.
April 13, 2026
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
CVRx, Inc.
March 2, 2026
1
2
Next
